Show Search Form
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | NHS: Drugs | ||||||||||||||
house id | 1 | ||||||||||||||
identifier | 167294 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 57 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask the Secretary of State for Health and Social Care, whether he has undertaken an impact assessment on the potential beneficial effects of regulating the dispensing of special medicinal products in England. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member constituency | Central Ayrshire | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Commons Tabled Parliamentary Question 2017/19 167294 | ||||||||||||||
type |
|
||||||||||||||
uin | 167294 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | NamedDay | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|